.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Fuji
Deloitte
Covington
Argus Health
Moodys
US Department of Justice
AstraZeneca
Medtronic
Baxter

Generated: January 19, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: eribulin mesylate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eisai IncHALAVENeribulin mesylateSOLUTION;INTRAVENOUS201532NDAEisai Inc.62856-389-011 VIAL in 1 CARTON (62856-389-01) > 2 mL in 1 VIAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Mallinckrodt
Teva
Healthtrust
Queensland Health
McKesson
Federal Trade Commission
Cerilliant
McKinsey
Accenture

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot